Delendrozen 70 mg/5,600 IU Film-coated tablets 
Composition:
Each film-coated tablet contains 70 mg Alendronic acid and (5,600 IU) Cholecalciferol (Vitamin D3).

Therapeutic indications: 
Delendrozen is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D insufficiency.

 It reduces the risk of vertebral and hip fractures.